Home
XtalPi

XtalPi Market Share Analysis for June 2026

欢迎访问晶泰媒体资料库。媒体库中的图像和视频仅供个人或编辑使用。请求更多信息您可以发送电子邮件至 press@xtalpi.com

Science and Education > Chemistry

Domainxtalpi.com

Year Founded2014

Employees501 - 1000

Annual Revenue$50M - $75M

XtalPi

XtalPi (including company regionals)

xtalpi.com

See more website traffic and engagement information

XtalPi Revenue up to June 2026 is 50M - 75M

revenue generated by XtalPi top domains

XtalPi top domains revenue over 3 years

Revenue for XtalPi top domains

xtalpi.com50M - 75M

See more with Sales Intelligence

Total visits to XtalPi's top domains

Understand XtalPi market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

xtalpi.com38.2K

See more with Sales Intelligence

Avg. visit duration in XtalPi's top domains

Analyze XtalPi engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

xtalpi.com00:00:30

See more with Sales Intelligence

Avg. pageviews on XtalPi's top domains

See how XtalPi keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

xtalpi.com1.56

See more with Sales Intelligence

XtalPi top competitors by domain

Top similar sites in June 2026, ranked by their affinity

laboro.aiCompany NameLaboro.AIEmployees51 - 200HQJapan, TokyoAnnual revenue< $1MTotal visits27.3KBusiness and Consumer Services > Business Services

Top technologies used by XtalPi

These are the website technologies, by industry, used by XtalPi top domains

Content Management System (5)

WordPress

Advertising (4)

DoubleClick

Widget (4)

Twemoji

Conversion & Analytics (3)

Google Analytics

More Technologies

7

See all

News & Signals from XtalPi

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsXtalPi Inc. is developing oral small molecule therapeutics for a GPCR target on Jun 10th '26.XtalPi announces strategic partnership with a leading biopharma to develop oral small molecule therapeutics for a GPCR target.

NewsXtalPi Inc. partnered with PharmaEngine, Inc. on May 4th '26.XtalPi (2228.HK), a leading AI- and robotics-powered innovation platform, today announced dual breakthroughs in its strategic partnership with PharmaEngine (4162.TWO) PEP08, a next-generation PRMT5 inhibitor discovered via XtalPi's platform, has successfully begun enrollments in a Phase I solid tumor trial, achieving a new clinical milestone.

NewsXtalPi Inc. had earnings of $37.7M on Jul 1st '25.XtalPi reported its first full-year profit in 2025, with revenue of RMB 800 million (USD 112 million), up over 200% year-on-year, and net profit of RMB 258 million (USD 36 million).